T. Rowe Price Associates »

Lb Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Lb Pharmaceuticals (LBRX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $327k 13k 24.72
2025-12-31 $247k 11k 22.30
2025-09-30 $4.5M 283k 15.79

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Lb Pharmaceuticals

Deep Track Capital
BlackRock
RA Capital Management
Trails Edge Capital Partners
Commodore Capital
Jpmorgan Chase & Co
TCG Crossover Management
Caligan Partners
Spruce Street Capital
Nantahala Capital Management
Vanguard Capital Management
Balyasny Asset Management
Alyeska Investment Group
Vivo Capital
Nan Fung Group Holdings

View all funds holding Lb Pharmaceuticals